Literature DB >> 18003856

Glial cell line-derived neurotrophic growth factor increases motility and survival of cultured mesenchymal stem cells and ameliorates acute kidney injury.

Haikun Shi1, Daniel Patschan, Gunnar P H Dietz, Mathias Bähr, Matthew Plotkin, Michael S Goligorsky.   

Abstract

Glial cell line-derived neurotrophic growth factor (GDNF), a member of the transforming growth factor family, is necessary for renal organogenesis and exhibits changes in expression in models of renal disease. Nestin is an intermediate filament protein originally believed to be a marker of neuroepithelial stem cells and recently proposed as a marker of mesenchymal stem cells (MSC). Having demonstrated the participation of nestin-expressing cells in renoprotection during acute renal ischemia, we hypothesized that growth factors and transcription factors similar to those operating in the nervous system should be also operant in the kidney and may be induced after noxious stimuli, such as an ischemic episode. Using cultured kidney-derived MSC, which abundantly express nestin, we confirmed expression of GDNF by these cells and demonstrated the GDNF-induced expression of GDNF. The cellular expression of nestin paralleled that of GDNF: serum starvation decreased the expression, whereas application of GDNF resulted in a dose-dependent increase in nestin expression. Immunohistochemical and Western blot analyses of kidneys obtained from control and postischemic mice showed that expression of GDNF was much enhanced in the renal cortex, a pattern similar to the previously reported expression of nestin. Based on the observed GDNF-induced GDNF expression, we next explored the effect of supplemental GDNF administered early after ischemia on renal function postischemia. GDNF-treated mice were protected against acute ischemia. To address potential mechanisms of the observed renoprotection, in vitro studies showed that GDNF accelerated MSC migration in a wound-healing assay. Hypoxia did not accelerate, but rather slightly reduced, the motility of MSC and reduced the expression of GDNF in MSC by approximately twofold. Furthermore, GDNF was cytoprotective against oxidative stress-induced apoptotic death of MSC. Collectively, these data establish 1) an autoregulatory circuit of GDNF-induced GDNF expression in renal MSC; 2) induction of GDNF expression in postischemic kidneys; 3) the ability of exogenous GDNF to ameliorate ischemic renal injury; and 4) a possible contribution of GDNF-induced motility and improved survival of MSC to renoprotection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18003856     DOI: 10.1152/ajprenal.00386.2007

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  13 in total

1.  Human amniotic fluid stem cell preconditioning improves their regenerative potential.

Authors:  Cinzia Rota; Barbara Imberti; Michela Pozzobon; Martina Piccoli; Paolo De Coppi; Anthony Atala; Elena Gagliardini; Christodoulos Xinaris; Valentina Benedetti; Aline S C Fabricio; Elisa Squarcina; Mauro Abbate; Ariela Benigni; Giuseppe Remuzzi; Marina Morigi
Journal:  Stem Cells Dev       Date:  2011-12-23       Impact factor: 3.272

2.  Glial cell line-derived neurotrophic factor induced the differentiation of amniotic fluid-derived stem cells into vascular endothelial-like cells in vitro.

Authors:  Ruyu Zhang; Ying Lu; Ju Li; Jia Wang; Caixia Liu; Fang Gao; Dong Sun
Journal:  J Mol Histol       Date:  2015-12-28       Impact factor: 2.611

3.  In Vitro Conditioned Bone Marrow-Derived Mesenchymal Stem Cells Promote De Novo Functional Enteric Nerve Regeneration, but Not Through Direct-Transdifferentiation.

Authors:  Rong Lin; Zhen Ding; Huan Ma; Huiying Shi; Yuanjun Gao; Wei Qian; Weina Shi; Zhaoli Sun; Xiaohua Hou; Xuhang Li
Journal:  Stem Cells       Date:  2015-09-29       Impact factor: 6.277

4.  Semaphorin 3A inactivation suppresses ischemia-reperfusion-induced inflammation and acute kidney injury.

Authors:  Punithavathi Ranganathan; Calpurnia Jayakumar; Riyaz Mohamed; Neal L Weintraub; Ganesan Ramesh
Journal:  Am J Physiol Renal Physiol       Date:  2014-05-14

5.  Expression of glial cell-derived neurotrophic factor and its receptor in the stem-cell-containing human limbal epithelium.

Authors:  H Qi; D-Q Li; F Bian; E Y Chuang; D B Jones; S C Pflugfelder
Journal:  Br J Ophthalmol       Date:  2008-09       Impact factor: 4.638

6.  Repeated systemic administration of human adipose-derived stem cells attenuates overt diabetic nephropathy in rats.

Authors:  Li Zhang; Kanghua Li; Xiangfei Liu; Diangeng Li; Congjuan Luo; Bo Fu; Shaoyuan Cui; Fei Zhu; Robert Chunhua Zhao; Xiangmei Chen
Journal:  Stem Cells Dev       Date:  2013-08-21       Impact factor: 3.272

7.  Podocyte repopulation contributes to regression of glomerular injury induced by ACE inhibition.

Authors:  Daniela Macconi; Fabio Sangalli; Maria Bonomelli; Sara Conti; Lucia Condorelli; Elena Gagliardini; Giuseppe Remuzzi; Andrea Remuzzi
Journal:  Am J Pathol       Date:  2009-01-22       Impact factor: 4.307

8.  Neurotrophin-induced migration and neuronal differentiation of multipotent astrocytic stem cells in vitro.

Authors:  Martha Douglas-Escobar; Candace Rossignol; Dennis Steindler; Tong Zheng; Michael D Weiss
Journal:  PLoS One       Date:  2012-12-12       Impact factor: 3.240

9.  Angiopoietin-1 treated early endothelial outgrowth cells (eEOCs) are activated in vitro and reduce renal damage in murine acute ischemic kidney injury (iAKI).

Authors:  Daniel Patschan; Jörg Rinneburger; Nazif Idrizi; Rico Backhaus; Katrin Schwarze; Elvira Henze; Susann Patschan; Gerhard A Müller
Journal:  BMC Nephrol       Date:  2013-10-21       Impact factor: 2.388

Review 10.  Mesenchymal stem cells as a therapeutic approach to glomerular diseases: benefits and risks.

Authors:  Uta Kunter; Song Rong; Marcus J Moeller; Jürgen Floege
Journal:  Kidney Int Suppl (2011)       Date:  2011-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.